ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
17.24
-0.66 (-3.69%)
At close: Aug 1, 2025, 4:00 PM
17.28
+0.04 (0.23%)
After-hours: Aug 1, 2025, 4:00 PM EDT
Oncternal Therapeutics Market Cap
ImageneBio has a market cap or net worth of $192.77 million as of August 1, 2025.
Market Cap
192.77M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$17.24
Market Cap Chart
Since July 29, 2025, ImageneBio's market cap has increased from $176.32M to $192.77M, an increase of 9.33%. That is a compound annual growth rate of 1,176,311,199.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 200.15M | 17.07% |
| Jul 30, 2025 | 170.97M | -3.04% |
| Jul 29, 2025 | 176.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |